Market Overview:
The global joint pain hyaluronic acid injection market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of joint pain, rising geriatric population, and growing demand for minimally invasive procedures. Based on type, the knee and ankle segment is expected to account for the largest share of the global joint pain hyaluronic acid injection market in 2018. This segment is also projected to grow at a higher CAGR than other segments during the forecast period. Factors such as increasing incidence of arthritis and other musculoskeletal disorders are driving growth in this segment. Based on application, hospital pharmacies are expected to account for the largest share of the global joint pain hyaluronic acid injection market in 2018.
Product Definition:
Hyaluronic acid injection is used to treat joint pain. It is a type of medication called a viscosupplement. It works by lubricating the joint and helping to reduce inflammation.
Knee and Ankle:
Knee and ankle are the two joints of the human body that allow motion in all four directions. Knee joint is formed by the meeting of femur (thigh bone) and tibia (shinbone). Ankle joint consists of a knob on one end, called an "ankle bone", which is connected to a smaller Bone -to- Bone structure at its other end.
Hip Joint:
A hip joint is a connection between two bones in the body. It enables the weight of the upper body to be borne by muscles, tendons and ligaments that cross both above and below the joint. A hip flexer is a group of muscles which aids in bringing your leg forward (inward). The hip flexor assists with moving your leg toward your chest (hips), while also moving it away from your chest (your pelvis).
Application Insights:
The others segment held the largest share of the global joint pain hyaluronic acid injection market in 2017. This is due to a high prevalence of conditions such as rheumatoid arthritis, osteoarthritis, gout and fibromyalgia that require long-term treatment with anti-inflammatory drugs. These aforementioned factors are expected to create growth opportunities for players offering Joint Pain Hyaluronic Acid Injection during the forecast period.
The knee and ankle joint was observed as one of the major application segments in 2017 owing to a large patient base suffering from osteoarthritis or rheumatoid arthritis at some point in their life. The increasing geriatric population across developed countries is also expected to contribute towards market growth over next few years on account of rising incidence rates for these diseases among older people globally.
Regional Analysis:
North America dominated the global joint pain hyaluronic acid injection market in 2017. The presence of a large number of players coupled with high healthcare expenditure and favorable reimbursement policies are some factors that can be attributed to its largest share. In addition, the availability of technologically advanced products is anticipated to drive growth during the forecast period.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing geriatric population, which increases susceptibility towards chronic joint diseases such as osteoarthritis and rheumatoid arthritis. Moreover, an increase in disposable income levels will also contribute towards this trend by enabling people avail medical services for treating their conditions at private hospitals or clinics rather than government run facilities.
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace. This is expected to drive the demand for Joint Pain Hyaluronic Acid Injection products, as they are commonly used to treat joint pain and other age-related conditions.
- Rising awareness about benefits of Joint Pain Hyaluronic Acid Injection: There is a growing awareness among people about the benefits of using Joint Pain Hyaluronic Acid Injection products for treating various medical conditions, including joint pain. This is likely to boost the demand for these products in the coming years.
- Technological advancements: The development of new and innovative technologies has led to the introduction of novel Joint Pain Hyaluronic Acid Injection products in the market, which are more effective and safer than traditional ones. This is likely to fuel market growth in the near future.
Scope Of The Report
Report Attributes
Report Details
Report Title
Joint Pain Hyaluronic Acid Injection Market Research Report
By Type
Knee and Ankle, Hip Joint, Shoulder and Elbow, Facet Joints of The Spine, Others
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Fresenius Medical Care, Allergan, Pfizer, Sanofi, Anika Therapeutics, Ferring, Bioventus, Flexion Therapeutics, Zimmer Biomet, SEIKAGAKU, Chugai Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
225
Number of Tables & Figures
158
Customization Available
Yes, the report can be customized as per your need.
Global Joint Pain Hyaluronic Acid Injection Market Report Segments:
The global Joint Pain Hyaluronic Acid Injection market is segmented on the basis of:
Types
Knee and Ankle, Hip Joint, Shoulder and Elbow, Facet Joints of The Spine, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Fresenius Medical Care
- Allergan
- Pfizer
- Sanofi
- Anika Therapeutics
- Ferring
- Bioventus
- Flexion Therapeutics
- Zimmer Biomet
- SEIKAGAKU
- Chugai Pharma
Highlights of The Joint Pain Hyaluronic Acid Injection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Knee and Ankle
- Hip Joint
- Shoulder and Elbow
- Facet Joints of The Spine
- Others
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Joint Pain Hyaluronic Acid Injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Joint pain hyaluronic acid injection is a medical procedure that uses hyaluronic acid to treat joint pain. Hyaluronic acid is a type of sugar molecule that helps keep the joints lubricated and in good condition. The injections are given into the affected joint, usually once every two weeks.
Some of the key players operating in the joint pain hyaluronic acid injection market are Fresenius Medical Care, Allergan, Pfizer, Sanofi, Anika Therapeutics, Ferring, Bioventus, Flexion Therapeutics, Zimmer Biomet, SEIKAGAKU, Chugai Pharma.
The joint pain hyaluronic acid injection market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Joint Pain Hyaluronic Acid Injection Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Joint Pain Hyaluronic Acid Injection Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Joint Pain Hyaluronic Acid Injection Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Joint Pain Hyaluronic Acid Injection Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Joint Pain Hyaluronic Acid Injection Market Size & Forecast, 2020-2028
4.5.1 Joint Pain Hyaluronic Acid Injection Market Size and Y-o-Y Growth
4.5.2 Joint Pain Hyaluronic Acid Injection Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Knee and Ankle
5.2.2 Hip Joint
5.2.3 Shoulder and Elbow
5.2.4 Facet Joints of The Spine
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Joint Pain Hyaluronic Acid Injection Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Joint Pain Hyaluronic Acid Injection Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Knee and Ankle
9.6.2 Hip Joint
9.6.3 Shoulder and Elbow
9.6.4 Facet Joints of The Spine
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Knee and Ankle
10.6.2 Hip Joint
10.6.3 Shoulder and Elbow
10.6.4 Facet Joints of The Spine
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Knee and Ankle
11.6.2 Hip Joint
11.6.3 Shoulder and Elbow
11.6.4 Facet Joints of The Spine
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Knee and Ankle
12.6.2 Hip Joint
12.6.3 Shoulder and Elbow
12.6.4 Facet Joints of The Spine
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Knee and Ankle
13.6.2 Hip Joint
13.6.3 Shoulder and Elbow
13.6.4 Facet Joints of The Spine
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Joint Pain Hyaluronic Acid Injection Market: Competitive Dashboard
14.2 Global Joint Pain Hyaluronic Acid Injection Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Fresenius Medical Care
14.3.2 Allergan
14.3.3 Pfizer
14.3.4 Sanofi
14.3.5 Anika Therapeutics
14.3.6 Ferring
14.3.7 Bioventus
14.3.8 Flexion Therapeutics
14.3.9 Zimmer Biomet
14.3.10 SEIKAGAKU
14.3.11 Chugai Pharma
